+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-06-18Number of Pages: 94

Aptamers Market (Type - Nucleic Acid Aptamers and Peptide Aptamers; Application - Therapeutics Development, Diagnostics, and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research
               1.3.1.3 Assumptions
1.4 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Aptamers Market (2012 & 2019)
      2.1.1 Global Aptamers Market by Types, 2012 (USD Million)
2.2 Comparative Analysis: Global Aptamers Market, By Geography, 2012 and 2019 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Event Impact Analysis
3.3 Market Dynamics
      3.3.1 Market Drivers
               3.3.1.1 Increasing interest of research scientists in the field of aptamer technology owing to various advantages over antibodies
               3.3.1.2 Rising support and participation of private organizations aiming to increase advancements in aptamer field
      3.3.2 Market Restraints
               3.3.2.1 Inadequate regulatory policies and ethical issues related to aptamer development
               3.3.2.2 Lack of knowledge and unfavorable characteristics of aptamers will lead low acceptance
      3.3.3 Market Opportunities
               3.3.3.1 Modification in aptamer chemistry will offer high acceptance
3.4 Porter’s Five Force Analysis
      3.4.1 Bargaining power of suppliers – Low - Medium
      3.4.2 Bargaining power of buyers – Low - Medium
      3.4.3 Threat of substitutes – High – Medium
      3.4.4 Threat of new entrants – Medium - High
      3.4.5 Competitive rivalry – Low - Medium
3.5 Market Attractiveness Analysis: Global Aptamers Market, by Geography
 
Chapter 4 Aptamers Market, by Types
4.1 Introduction
      4.1.1 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million)
4.2 Nucleic Acid Aptamers
      4.2.1 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million)
4.3 Peptide Aptamers
      4.3.1 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 5 Aptamers Market, by Applications
5.1 Overview
      5.1.1 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Therapeutics Development
      5.2.1 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million)
5.3 Diagnostics (Molecular Imaging, Biomarker Detection and Discovery)
      5.3.1 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million)
5.4 Research and Development Applications (Targeted Drug Delivery, Drug Discovery and Development)
      5.4.1 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million)
5.5 Others (Biosensor and Food Safety)
      5.5.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 6 Aptamers Market, by Geography
6.1 Overview
      6.1.1 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 7 Competitive Landscape
7.1 Market Share by Key Players of Global Aptamers Market, 2012 (%)
      7.1.1 Global Aptamers Market Share Analysis, by Key Players, 2012 (%)
 
Chapter 8 Recommendations
8.1 Market Strategy for Success
      8.1.1 Focus on emerging aptamer selection technologies that improves aptamer affinity and specificity
      8.1.2 Focus on investing in research and development activities
 
Chapter 9 Company Profiles
9.1 AM Biotechnologies, LLC
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Aptagen, LLC
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Aptamer group
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies 
      9.3.5 Recent Developments
9.4 Aptamer Sciences, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies 
      9.4.5 Recent Developments
9.5 Base Pair Biotechnologies, Inc.
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies 
      9.5.5 Recent Developments
9.6 Bioapter S.L.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies 
9.7 CD Genomics
      9.7.1 Company Overviews
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies 
9.8 Neo Ventures Biotechnology, Inc.
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies 
      9.8.5 Recent Developments
9.9 NOXXON Pharma AG
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies 
      9.9.5 Recent Developments
9.10 Optech Biotech
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies 
      9.10.5 Recent Developments
9.11 Ophthotech Corporation
      9.11.1 Company Overview
      9.11.2 Product Portfolio
      9.11.3 Business Strategies 
9.12 Regado Biosciences, Inc.
      9.12.1 Company Overview
      9.12.2 Financial Overview
      9.12.3 Product Portfolio
      9.12.4 Business Strategies 
      9.12.5 Recent Developments
9.13 Somalogic, Inc.
      9.13.1 Company Overview
      9.13.2 Financial Overview
      9.13.3 Product Portfolio
      9.13.4 Business Strategies 
      9.13.5 Recent Developments
9.14 TriLink Biotechnologies, Inc.
      9.14.1 Company Overview
      9.14.2 Financial Overview
      9.14.3 Product Portfolio
      9.14.4 Business Strategies 
      9.14.5 Recent Developments
9.15 Vivonics, Inc.
      9.15.1 Company Overview
      9.15.2 Financial Overview
      9.15.3 Product Portfolio
      9.15.4 Business Strategies
      9.15.5 Recent Developments

List of Figures
 
FIG. 1 Aptamers Market Segmentation
FIG. 2 Global Aptamers Market, by Types, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Aptamers Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Aptamers Market
FIG. 5 Market Attractiveness Analysis: Global Aptamers Market, by Geography, 2012 Value (%)
FIG. 6 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 North America Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Aptamers Market: Market Share, by Key Players, 2012 (%)

List of Table
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Aptamers Market (2012 & 2019)
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million)


 
 
Back To Top